Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EV/Core EBITDA(x) 2.915.004.895.348.70

What is the latest EV/Core EBITDA ratio of VENUS REMEDIES ?

The latest EV/Core EBITDA ratio of VENUS REMEDIES is 2.91 based on Mar2023 Consolidated results.
Year EV/Core EBITDA
Mar20232.91
Mar20225.00
Mar20214.89
Mar20205.34
Mar20198.70

How is EV/Core EBITDA of VENUS REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2023 2.91
-41.80
Mar2022 5
2.25
Mar2021 4.89
-8.43
Mar2020 5.34
-38.62
Mar2019 8.7 -

Other Financial Ratios of VENUS REMEDIES


Compare EV/Core EBITDA ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹399.3 Cr -2.8% -12.1% 48.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹370,757.0 Cr 1.6% -3.7% 60% Stock Analytics
CIPLA ₹109,559.0 Cr -2% -4.6% 49.9% Stock Analytics
DIVIS LABORATORIES ₹103,416.0 Cr -0.9% 4.2% 14.3% Stock Analytics
ZYDUS LIFESCIENCES ₹99,088.9 Cr -2.1% -0.9% 89.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,939.0 Cr -3.1% -4.7% 21.6% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-2.8%

-12.1%

48.5%

SENSEX

-0.6%

-2.1%

18.4%


You may also like the below Video Courses